Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for prevention of paclitaxel-induced neuropathy in breast cancer
IRCT20151021024645N3Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of metformin in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Prevention of paclitaxel-induced neuropathy. Started Nov 2021; status: completed.
02
Drugs
metformin
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on IRCT20151021024645N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151021024645N3.